Selectivity of the P2X3 receptor antagonist Eliapixant, and its potential use in the treatment of endometriosis Michelle C. Fletcher Journal Club 03 January 2022 Pages: 1 - 3
A major role for adenosine A2A receptor in the interaction between astrocytes and myelinated neurons: possible implications for the therapy of neurodegenerative disorders Zaira BoussadiaValentina ChiodiAlberto Martire Journal Club 23 January 2022 Pages: 5 - 7
Engineered yeast-based eATP precisely controlled system for the treatment of inflammatory bowel disease Adnan Hassan TahirYong Tang Journal Club 17 January 2022 Pages: 9 - 11
A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling Djo HasanAtsuko ShonoToru Kotani Commentary Open access 10 November 2021 Pages: 13 - 59
Novel possibility for cutaneous melanoma treatment by means of rosmarinic acid action on purinergic signaling Gilnei Bruno da SilvaMilena Ayumi YamauchiMargarete Dulce Bagatini Review Article 05 November 2021 Pages: 61 - 81
Involvement of P2X7 receptors in chronic pain disorders Wen-Jing RenPeter Illes Review Article Open access 20 November 2021 Pages: 83 - 92
Purinergic modulation of the immune response to infections Natalia EberhardtGastón BergeroM. Pilar Aoki Review Article 08 January 2022 Pages: 93 - 113
Mono-ADP-ribosylation sites of human CD73 inhibit its adenosine-generating enzymatic activity Julia HesseMona K. RosseJürgen Schrader Brief Communication Open access 27 December 2021 Pages: 115 - 121
Is the regulation by miRNAs of NTPDase1 and ecto-5’-nucleotidase genes involved with the different profiles of breast cancer subtypes? Fernanda Cardoso da SilvaAngelo Borges de Melo NetoCristina Ribas Fürstenau Original Article 05 November 2021 Pages: 123 - 133
P2X7 receptor: the regulator of glioma tumor development and survival Damian MatyśniakVira ChumakPaweł Pomorski Original Article Open access 29 December 2021 Pages: 135 - 154